Annual Drug Patent Expirations for DROSPIRENONE Drospirenone is a drug marketed by Exeltis Usa Inc, Barr, Glenmark Pharms Ltd, Hetero Labs Ltd, Hlthcare, Jubilant Cadista, Mylan Labs Ltd, Watson Labs,…
The post New patent for Exeltis Usa drug DROSPIREN…
Annual Drug Patent Expirations for SLYND Slynd is a drug marketed by Exeltis Usa Inc and is included in one NDA. There are nine patents protecting this drug. SLYND drug…
The post New patent for Exeltis Usa drug SLYND appeared first on DrugPatentWatch -…
Annual Drug Patent Expirations for SLYND Slynd is a drug marketed by Exeltis Usa Inc and is included in one NDA. There are nine patents protecting this drug. SLYND drug…
The post New patent for Exeltis Usa drug SLYND appeared first on DrugPatentWatch -…
[](//www.DrugPatentWatch.com/p/preview/generic-api/saxagliptin?utm_medium=dpw_wp_blog&utm_campaign=dpw_wp_blog&utm_source=dpw_wp_blog) Saxagliptin is the generi…
New tentative approval for Amneal Pharms drug saxagliptin Read Post »
This chart shows the drugs with the most patents in Netherlands. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.…
The post Which pharmaceutical drugs have the most drug patents in Net…
Which pharmaceutical drugs have the most drug patents in Netherlands? Read Post »
Annual Drug Patent Expirations for RECORLEV Recorlev is a drug marketed by Strongbridge and is included in one NDA. There are six patents protecting this drug. This drug has twenty-eight…
The post New patent for Strongbridge drug RECORLEV appeared firs…
[](//www.DrugPatentWatch.com/p/preview/generic-api/eltrombopag?utm_medium=dpw_wp_blog&utm_campaign=dpw_wp_blog&utm_source=dpw_wp_blog) Eltrombopag is the generi…
New tentative approval for Teva Pharms drug eltrombopag Read Post »
Annual Drug Patent Expirations for CERDELGA Cerdelga is a drug marketed by Genzyme Corp and is included in one NDA. It is available from one supplier. There are six patents…
The post New patent for Genzyme Corp drug CERDELGA appeared first on DrugPaten…
Annual Drug Patent Expirations for YUPELRI Yupelri is a drug marketed by Mylan Ireland Ltd and is included in one NDA. It is available from one supplier. There are sixteen…
The post New patent for Mylan Ireland drug YUPELRI appeared first on DrugPatent…
Annual Drug Patent Expirations for TRINTELLIX Trintellix is a drug marketed by Takeda Pharms Usa and is included in one NDA. It is available from three suppliers. There are ten…
The post New patent for Takeda Pharms drug TRINTELLIX appeared first on Dr…
Get new actionable insights and updates from BiotechBlog
